-
Bellicum Pharmaceuticals Appoints Shane Ward as General Counsel
29 May 2018 11:00 GMT
… Miles
646-513-3125
bmiles@bmccommunications.com
-
Bellicum Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
30 May 2018 11:00 GMT
… Miles
646-513-3125
bmiles@bmccommunications.com
-
Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
29 May 2018 11:00 GMT
… Miles, 646-513-3125
bmiles@bmccommunications.com
-
Chi-Med to Present at Bank of America Merrill Lynch Annual Health Care Conference
11 May 2018 11:34 GMT
… (917) 570 7340 (Mobile)
bmiles@bmccommunications.com
Susan Duffy, BMC Communications
+1 … (917) 499 8887 (Mobile)
sduffy@bmccommunications.com
Investor Relations
Matt Beck, The …
-
Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute
22 May 2018 09:07 GMT
… Miles, 646-513-3125 bmiles@bmccommunications.com Copyright (C) 2018 GlobeNewswire, Inc …
-
Ascentage Pharma Announces Promising Phase 1 Interim Results in Two Clinical Programs to Be Presented at 2018 ASCO Annual Meeting
21 May 2018 11:57 GMT
… Amy Bonanno E-mail: abonanno@bmccommunications.com
Phone: +1 914 450 0349 …
-
Bellicum Announces Clinical Presentations on Lead Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association
17 May 2018 13:20 GMT
… Miles
646-513-3125
bmiles@bmccommunications.com Source: Bellicum Pharmaceuticals
-
Bellicum Announces Oral Presentation on Dual-Switch CAR-T Technology at the 21st Annual Meeting of the American Society of Gene and Cell Therapy
15 May 2018 11:00 GMT
… Miles
646-513-3125
bmiles@bmccommunications.com
-
Aileron Therapeutics Announces Changes to Management
15 May 2018 20:12 GMT
… Miles, 646-513-3125
bmiles@bmccommunications.com Source: Aileron Therapeutics GlobeNewswire
globenewswire …
-
CureVac Announces New Management Structure
08 May 2018 10:00 GMT
… : +1 646 513-3125
bmiles@bmccommunications.com
About
© 1995-2025